Physician profile
Warren T Kim
NPI 1063532778
$439,304.49
in general payments reported to CMS, 2019-2025
8 companies · $106K in 2025
The $106K reported for 2025 was more than what 99% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $7,669 · 2021: $17K · 2022: $60K · 2023: $121K · 2024: $117K · 2025: $106K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $333K · Travel and Lodging: $8,356 · Food and Beverage: $2,733.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $333,082.72 |
| Travel and Lodging | $8,356.41 |
| Food and Beverage | $2,732.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Route 92 Medical, INC. | $420,269.36 | 2020-2025 | 8f Base Camp Sheath System |
| Stryker Corporation | $18,068.60 | 2019-2025 | Target, Surpass Evolve, Trevo |
| Medtronic USA, INC. | $585.95 | 2019-2020 | |
| Depuy Synthes Sales INC. | $147.43 | 2020-2025 | Trufill |
| Microvention, INC. | $90.50 | 2021 | |
| Balt USA, LLC | $86.00 | 2019 | |
| Sk Life Science, INC. | $34.02 | 2022 | |
| Penumbra, INC. | $22.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,325,211.75 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Warren Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.